Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00076 Norepinephrine [1] 22
2 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00095 Epinephrine [3] 46, 70, 96
3 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00124 Ephedrine [1] 11
4 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00270 Chlorpromazine [1] 254
5 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00281 Clonidine [4] 6, 65, 70, 78
6 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00283 Clozapine [1] 6
7 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00405 Methyldopa [1] 323
8 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00485 Pseudoephedrine [1] 17
9 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00514 Dexmedetomidine [13] 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280
10 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00560 Pimozide [1] 2
11 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00604 Clonidine [4] 6, 65, 70, 78
12 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00606 Guanfacine [1] 193
13 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00680 Methylergometrine [3] 118, 280, 288
14 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00776 Tizanidine [1] 13
15 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00789 Chlorpromazine [1] 254
16 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D00996 Epinephrine [3] 46, 70, 96
17 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D01008 Apraclonidine [1] 11
18 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D01205 Dexmedetomidine [13] 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280
19 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D01277 Droxidopa [5] 5, 6, 17, 169, 170
20 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02076 Brimonidine [2] 13, 90
21 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02149 Epinephrine [3] 46, 70, 96
22 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02268 Ergoloid mesylate [2] 6, 206
23 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02349 Dipivefrin [1] 6
24 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D03274 Chlorpromazine [1] 254
25 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D04034 Chlorpromazine [1] 254
26 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D04375 Guanabenz [2] 2, 13
27 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D05206 Norepinephrine [1] 22
28 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D05648 Pseudoephedrine [1] 17
29 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D05649 Pseudoephedrine [1] 17
30 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D07461 Apraclonidine [1] 11
31 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D07540 Brimonidine [2] 13, 90
32 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08031 Guanfacine [1] 193
33 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08205 Methyldopa [1] 323
34 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08207 Methylergometrine [3] 118, 280, 288
35 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08449 Pseudoephedrine [1] 17
36 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08482 Rilmenidine [1] 8
37 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08611 Tizanidine [1] 13
38 ADRA2A [2] cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D08685 Yohimbine [1] 6
39 TYMS [4] Pyrimidine metabolism, One carbon pool by folate, Metabolic pathways, Antifolate resistance D01223
(Name: CAPECITABINE 150MG)		 Capecitabine
(Synonym:CAPECITABINE 150MG)		[1] 94